文献速递心力衰竭与心肌病

左向右分流在心力衰竭中的治疗作用

Therapeutic left-to-right shunting in heart failure.
PubMed 文献 · Eur Heart J · 2025-01-01

本综述讨论左向右分流作为心力衰竭的非药物治疗手段,旨在降低左心房高压、改善症状与结局。文章梳理了该疗法的理论基础、已开展和正在进行的临床试验,并指出疗效是否受左室射血分数、肺血管阻力和右室结构功能影响尚存疑问。

要点

  • 左向右分流可降低左心房压力,是心衰非药物治疗的新兴方向。
  • 现有治疗下心衰住院率仍高,生活质量与功能改善有限。
  • 分流疗效是否受射血分数、肺血管阻力与右室功能影响尚不明确。

核心结论

  • 左向右分流是降低左心房高压、改善心衰症状与结局的潜在治疗选项,但该领域尚处早期,存在诸多未解问题。

研究设计与样本

  • 本文为综述,讨论左向右分流治疗心衰的理论基础,汇总已往和正在进行的临床试验,并提出未来方向。

主要发现

  • 射血分数降低或保留的心衰因液体负荷或运动导致左心房压升高,引起肺静脉淤血。
  • 现有治疗下心衰住院率仍高,生活质量评分与功能能力改善有限。
  • 近期数据对分流疗效是否因左室射血分数、肺血管阻力和/或右室结构与功能而异提出疑问。

临床怎么用

  • 左向右分流可作为降低左心房高压的非药物策略加以关注,但临床应用需结合射血分数、肺血管阻力和右室功能评估。

局限性

  • 本文为综述,未提供新的原始研究数据,相关疗效问题仍需临床试验解答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure with reduced or preserved ejection fraction is associated with elevated left atrial pressure at rest due to fluid overload or during exercise, leading to pulmonary venous congestion. Even with available treatments, heart failure hospitalizations remain high, and improvements in quality-of-life scores and functional capacity are modest. Thus, there is growing interest in non-pharmacological methods to decompress the left atrium and improve heart failure symptoms and outcomes. Left-to-right shunts have emerged as a potential therapeutic option to reduce left atrial hypertension, improve quality of life, and impact long-term outcomes. This nascent field carries both potential therapeutic promise and many unanswered questions. Recent data have questioned whether the effects of this therapy vary based on the left ventricular ejection fraction, pulmonary vascular resistance, and/or right ventricular structure and function. This review discusses the basis for left-to-right shunt therapies, synthesizes past and ongoing clinical trials, and offers future directions.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Fioretti, Nair, Anker, et al. Therapeutic left-to-right shunting in heart failure. Eur Heart J. 2025. PMID: 39943738. doi:10.1093/eurheartj/ehaf120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。